SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-22-000217
Filing Date
2022-03-14
Accepted
2022-03-14 08:05:11
Documents
15
Period of Report
2022-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 26445
2 PRESS RELEASE htbx_ex99z1.htm EX-99.1 18881
7 GRAPHIC image_002.jpg GRAPHIC 133641
  Complete submission text file 0001553350-22-000217.txt   444500

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE htbx-20220314.xsd EX-101.SCH 3548
4 XBRL DEFINITION FILE htbx-20220314_def.xml EX-101.DEF 26839
5 XBRL LABEL FILE htbx-20220314_lab.xml EX-101.LAB 36783
6 XBRL PRESENTATION FILE htbx-20220314_pre.xml EX-101.PRE 25461
9 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 5069
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 22735124
SIC: 2834 Pharmaceutical Preparations